Iclusig
Ended Awarded Last action
- Contract number
- 36C26024F0351
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $27,913
Award facts
- Contract value 100% obligated
- $27,913.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Earth City, MO 63045, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Health Administration awarded a delivery order for the oncology medication ICLUSIG (ponatinib) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. The $27,913.44 firm fixed price contract is against Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs, and has a completion date of May 18, 2024. This award is part of a larger single award blanket purchase agreement (BPA) the VA has in place with Takeda through October 2024, with a potential value exceeding $13 million, to efficiently procure specialty pharmaceuticals for use across multiple VA Integrated Service Networks serving veterans. No set-aside designation was used for this award.
Quick answers
Who was awarded contract 36C26024F0351?
36C26024F0351 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on April 18, 2024.
How much is contract 36C26024F0351 worth?
The government has obligated $27,913 on 36C26024F0351.
Is contract 36C26024F0351 an order under another contract?
Yes. 36C26024F0351 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0351 competed?
The extent of competition for 36C26024F0351 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award